24 Jan 2013 15:33
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | ARK THERAPEUTICS GROUP PLC | |||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||||||||
An acquisition or disposal of voting rights | x | |||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||||||||
An event changing the breakdown of voting rights | ||||||||||
Other (please specify): |
| |||||||||
3. Full name of person(s) subject to the notification obligation:
| Henderson Global Investors | |||||||||
4. Full name of shareholder(s) (if different from 3.):
| ||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached:
| 21 January 2013 | |||||||||
6. Date on which issuer notified:
| 23 January 2013 | |||||||||
7. Threshold(s) that is/are crossed or reached:
| 5% | |||||||||
8. Notified details: | ||||||||||
A: Voting rights attached to shares
| ||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | ||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||
ORD GBP 0.01 | 12,810,000 | 12,810,000 | 5,310,000 | 2.53% | ||||||
GB0034251727 | ||||||||||
B: Qualifying Financial Instruments | |||||||||
Resulting situation after the triggering transaction
| |||||||||
Type of financialinstrument | Expirationdate | Exercise/ConversionPeriod | Number of votingrights that may beacquired if theinstrument isexercised/ converted.
| % of votingrights | |||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | |||||||||
Resulting situation after the triggering transaction
| |||||||||
Type of financialinstrument | Exerciseprice | Expirationdate | Exercise/Conversionperiod | Number of votingrights instrumentrefers to | % of voting rights
| ||||
Nominal | Delta
| ||||||||
Total (A+B+C) | |||||||||
Number of voting rights | Percentage of voting rights | ||||||||
5,310,000 | 2.53% | ||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | |||||||||
Proxy Voting: | |||||||||
10. Name of the proxy holder: | |||||||||
11. Number of voting rights proxy holder will cease to hold: | |||||||||
12. Date on which proxy holder will cease to hold voting rights: | |||||||||
13. Additional information: | |||||||||
14. Contact name: | Balenkosi Dungeni | ||||||||
15. Contact telephone number: | 020 7818 3747 | ||||||||